Immusoft vs Outpace Bio

Immusoft logo

Immusoft

Cell therapy company dedicated to improving the lives of patients with rare diseases

22 employees · est. 2009 · Seattle, United States

VS
Outpace Bio logo

Outpace Bio

Revolutionizing Cell Therapy with Protein Design

74 employees · est. 2020 · Seattle, United States

Immusoft is the older company (2009 vs 2020); Outpace Bio is the larger of the two.

Side-by-Side Comparison

Immusoft Outpace Bio
Founded
2009 older 2020
Headquarters
Seattle, United States Seattle, United States
Employees
22 74 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Life Sciences
Funding Stage
Grant Series B
Total Funding
$49.27M $199.00M
Funding Rounds
12 4
Services
B Cell Programming, Therapeutic Protein Development, Clinical Research and Development, Biologics Optimization AI-powered protein design, Cell therapy development, Cytokine design for immune modulation, Safety and specificity enhancement of cell therapies, Translational models in oncology
Target Customers
Patients with Rare Diseases, Biopharmaceutical Companies, Healthcare Providers, Research and Development Organizations Pharmaceutical companies, Biotech firms, Oncology researchers, Healthcare institutions, Academic collaborators
Taxonomy
Cell TherapyRare DiseasesTherapeutic ProteinsImmune System ProgrammingB Cell ModificationGene-Encoded Medicines +6 Cell TherapyProtein DesignCellular EngineeringSolid TumorsImmune ResponseTumor Microenvironment +8
Website
immusoft.com outpacebio.com
Immusoft logo

About Immusoft

Immusoft, a pioneering cell therapy company, is committed to revolutionizing treatments for patients suffering from rare diseases. Utilizing a cutting-edge technology platform known as Immune System Programming (ISP™), Immusoft modifies a patient's B cells to act as miniature drug factories, produci...

Outpace Bio logo

About Outpace Bio

Outpace Bio, founded in 2020, is at the forefront of cell therapy innovation, leveraging advanced protein design to revolutionize treatment options, particularly targeting solid tumors. With their slogan, "Revolutionizing Cell Therapy with Protein Design", the company promises transformative advance...

Also comparing in this category

Comparing more than these two?

Get Immusoft, Outpace Bio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Immusoft compare?

A PDF of Immusoft and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Immusoft was founded in 2009, based in Seattle, United States, with 22 employees. Immusoft, a pioneering cell therapy company, is committed to revolutionizing treatments for patients suffering from rare diseases. Utilizing a cutting-edge technology platform known as Immune System P. Outpace Bio was founded in 2020, based in Seattle, United States, with 74 employees. Outpace Bio, founded in 2020, is at the forefront of cell therapy innovation, leveraging advanced protein design to revolutionize treatment options, particularly targeting solid tumors. With their slo.
Immusoft has raised $49.27M and Outpace Bio $199.00M. Latest stage: Immusoft Grant, Outpace Bio Series B.
Both work in Biotechnology, Health Care and Life Sciences and list cell therapy among their focus areas.

Compare Immusoft with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Immusoft on 11 Mar 2026, and Outpace Bio on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes